A pilot open study of long term high dose creatine augmentation in patients with treatment resistant negative symptoms schizophrenia.

IF 0.5 4区 医学 Q4 PSYCHIATRY Israel Journal of Psychiatry and Related Sciences Pub Date : 2015-01-01
Uri Levental, Yuly Bersudsky, Tzvi Dwalatzky, Vladimir Lerner, Sophie Medina, Joseph Levine
{"title":"A pilot open study of long term high dose creatine augmentation in patients with treatment resistant negative symptoms schizophrenia.","authors":"Uri Levental,&nbsp;Yuly Bersudsky,&nbsp;Tzvi Dwalatzky,&nbsp;Vladimir Lerner,&nbsp;Sophie Medina,&nbsp;Joseph Levine","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The effects of creatine on brain metabolism and the potential cognitive enhancing properties of this compound raise the possibility of developing a new augmentation therapeutic strategy in schizophrenia especially in patients demonstrating negative and cognitive symptomatology.</p><p><strong>Methods: </strong>Seven inpatients with chronic schizophrenia presenting with treatment resistant negative symptoms were enrolled into exploratory treatment study with creatine monohydrate augmentation at a daily high-dose of 10 grams, administered for 6 months. Several clinical rating scales and a computerized cognitive assessment battery were applied.</p><p><strong>Results: </strong>Creatine treatment mildly improved the schizophrenia symptomatology but there were no significant changes in cognitive functions. Several ward behaviors were also improved. Tardive parkinsonism improved numerically by above 40% in 4 out of 6 patients.</p><p><strong>Conclusion: </strong>This small, open design study of high dose creatine add-on for 6 months in chronic inpatients with schizophrenia demonstrated only mild positive effects on the patients' symptomatology and behavior and might have beneficial effect on tardive parkinsonism.</p>","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"52 1","pages":"6-10"},"PeriodicalIF":0.5000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Israel Journal of Psychiatry and Related Sciences","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The effects of creatine on brain metabolism and the potential cognitive enhancing properties of this compound raise the possibility of developing a new augmentation therapeutic strategy in schizophrenia especially in patients demonstrating negative and cognitive symptomatology.

Methods: Seven inpatients with chronic schizophrenia presenting with treatment resistant negative symptoms were enrolled into exploratory treatment study with creatine monohydrate augmentation at a daily high-dose of 10 grams, administered for 6 months. Several clinical rating scales and a computerized cognitive assessment battery were applied.

Results: Creatine treatment mildly improved the schizophrenia symptomatology but there were no significant changes in cognitive functions. Several ward behaviors were also improved. Tardive parkinsonism improved numerically by above 40% in 4 out of 6 patients.

Conclusion: This small, open design study of high dose creatine add-on for 6 months in chronic inpatients with schizophrenia demonstrated only mild positive effects on the patients' symptomatology and behavior and might have beneficial effect on tardive parkinsonism.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长期高剂量肌酸增强治疗难治性阴性症状精神分裂症患者的试点开放研究
背景:肌酸对脑代谢的影响和这种化合物潜在的认知增强特性,为精神分裂症特别是表现出阴性和认知症状的患者提供了一种新的增强治疗策略的可能性。方法:选取7例出现治疗抵抗阴性症状的住院慢性精神分裂症患者进行探索性治疗研究,每日大剂量增加一水肌酸10g,持续治疗6个月。应用了几种临床评定量表和计算机认知评估系统。结果:肌酸治疗轻度改善精神分裂症症状,但认知功能无明显改变。病房的一些行为也有所改善。迟发性帕金森病在6例患者中有4例的数值改善超过40%。结论:这项小型、开放设计的研究表明,高剂量肌酸对慢性住院精神分裂症患者的症状和行为只有轻微的积极作用,可能对迟发性帕金森病有有益的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
25.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: THE ISRAEL JOURNAL OF PSYCHIATRY publishes original articles dealing with the all bio-psycho-social aspects of psychiatry. While traditionally the journal has published manuscripts relating to mobility, relocation, acculturation, ethnicity, stress situations in war and peace, victimology and mental health in developing countries, papers addressing all aspects of the psychiatry including neuroscience, biological psychiatry, psychopharmacology, psychotherapy and ethics are welcome. The Editor also welcomes pertinent book reviews and correspondence. Preference is given to research reports of no more than 5,000 words not including abstract, text, references, tables and figures. There should be no more than 40 references and 4 tables or figures. Brief reports (1,500 words, 5 references) are considered if they have heuristic value. Books to be considered for review should be sent to the editorial office. Selected book reviews are invited by the editor.
期刊最新文献
Evidence Basis for Psychodynamic Self-Psychology in Eating Disorders - A Review Paper. Perversion and the universal law. Does Individual Stigma Predict Mental Health Funding Attitudes? Toward an Understanding of Resource Allocation and Social Climate. Mental Illness Stigma Expressed by Police to Police. 'People with Problems, Not Patients with Illnesses': Using Psychosocial Frameworks to Reduce the Stigma of Psychosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1